Kingdomway(SZ:002626)2022-12-07 09:31Group 1: Company Expansion Plans - The company is advancing into the health supplement sector, enhancing its competitive position in the nutrition fortifier and feed additive industries while actively expanding downstream in the supply chain [2] - The company has launched Coenzyme Q10 soft capsules, primarily sold through the "Jindawi Mall" channel, which is currently in trial operation [3] - The acquisition of Doctor's Best Holdings, Inc. allows the company to quickly enter the U.S. health supplement market and expand its product line, with approximately 180 dietary supplements ranked highly on platforms like Amazon and iHerb [3] Group 2: Product Production and Raw Materials - Coenzyme Q10, DHA, and plant-based ARA are produced through microbial fermentation, with main raw materials including liquid sugar, β-violet ketone, and cholesterol [3] - The production technology for Coenzyme Q10 is self-developed and patented, with stable price fluctuations and a rapidly growing market demand [3] - The price trends for VA and VD3 are influenced by raw material costs, supply conditions, and market expectations [4] Group 3: Market Development and Competitive Advantage - The company's products have been included in the qualified supplier lists of major domestic dairy enterprises, indicating strong market potential [4] - The company plans to increase research and promotion efforts for DHA and ARA in various application fields, leveraging its competitive advantages in production technology [4]